Ligand validation:6M81

TLO: 5'-O-[(S)-hydroxy{[(S)-hydroxy(phenoxy)phosphoryl]oxy}phosphoryl]thymidine

TLO is a Ligand Of Interest in 6M81 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6M81_TLO_C_302	78%	24%	0.101	0.943	1.2	1.89	4	9	0	0	100%	1
6M81_TLO_B_302	78%	24%	0.104	0.945	1.19	1.88	4	12	0	0	100%	1
6M81_TLO_A_302	70%	15%	0.11	0.927	1.43	2.3	6	16	0	0	100%	1
6M81_TLO_D_302	45%	11%	0.171	0.904	1.39	2.77	4	12	3	0	100%	1
3PFG_TLO_A_301	98%	23%	0.06	0.986	1.11	2.04	3	7	0	0	100%	1
6M83_TLO_A_302	79%	24%	0.092	0.937	1.13	1.93	2	10	1	0	100%	0.77
6M82_TLO_A_302	46%	18%	0.159	0.894	1.19	2.28	3	9	2	0	100%	1
3RC1_TLO_A_334	96%	16%	0.071	0.98	1.25	2.37	4	11	0	0	100%	1
3RC7_TLO_A_337	87%	18%	0.107	0.979	1.28	2.19	4	14	2	0	100%	1
4J7H_TLO_A_501	86%	24%	0.086	0.955	1.13	1.93	3	16	0	0	100%	1
3RC9_TLO_A_337	83%	14%	0.109	0.969	1.2	2.64	4	12	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.